Hello Health Rounds Readers! Today we feature two studies with potentially important new information involving widely used ...

Researchers hope findings will lead to new class of drugs for many different diseases for which proteolethargy is a common ...

Chronic diseases like type 2 diabetes and inflammatory disorders have a huge impact on humanity. They are a leading cause of ...

Corcept Therapeutics specializes in cortisol-modulating drugs. Click here to read why CORT stock offers investment potential.

Strong Interest in Trial Participation Resulted in Enrollment Exceeding Target by 20 Percent and Completion Ahead of ScheduleTop-line Data ...

Tamoxifen is a common and important treatment to prevent breast cancer from recurring. A new study shows that variation in a patient's gut microbiome can impact how effective the treatment is.

A new study has shown that variation in the microbiota of the human gut impacts the pharmacokinetics of tamoxifen and thus the effectiveness of the drug.

Washington, D.C.-A new study has shown that variation in the microbiota of the human gut impacts the pharmacokinetics of tamoxifen and thus the ...

More than 4.4 million people in the UK live with diabetes and new research has shown a link between a common food and ...

Monash University drug discovery researchers have found that a natural fat molecule called ‘lipoxin A4’ (LXA4) could significantly reduce inflammation and improve function for diabetic hearts.